Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab: The role of hepatocanalicular transporter variants.
about
Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab: The role of hepatocanalicular transporter variants.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Persisting hyperbilirubinemia ...... alicular transporter variants.
@en
Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria
@nl
type
label
Persisting hyperbilirubinemia ...... alicular transporter variants.
@en
Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria
@nl
prefLabel
Persisting hyperbilirubinemia ...... alicular transporter variants.
@en
Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria
@nl
P2093
P2860
P356
P1476
Persisting hyperbilirubinemia ...... alicular transporter variants.
@en
P2093
Alexander Röth
Colin Vance
Dörte Herich-Terhürne
Frank Lammert
Susanne N Weber
Ulrich Dührsen
P2860
P304
P356
10.1111/EJH.12927
P577
2017-07-10T00:00:00Z